142
Views
50
CrossRef citations to date
0
Altmetric
Research Article

Use of Targeting Agents to Increase Uptake and Localization of Drugs to the Intestinal Epithelium

Pages 113-123 | Published online: 03 Oct 2008

References

  • Adriaens, E., Ameye, D., Dhondt, M.M.M., Foreman, P. and Remon, J.P. (2003) “Evaluation of the mucosal irritation potency of co-spray dried Amioca/poly(acrylic acid) and Amioca/Carbopol 974P mixtures”, J. Control. Release 88, 393–399.
  • Aizpurua, de H.J. and Russell-Jones, G.J. (1987) “Oral vaccination: identification of classes of proteins which provoke an immune response upon oral feeding”, J. Exp. Med. 167, 440–451.
  • Alsenz, J., et al. (2000) “Oral absorption of peptides through the cobalamin (vitamin B12) pathway in the rat intestine”, Pharm. Res. July 17(7),825–832.
  • Amorim, M.J.L.G., de, B. and Ferreira, J.P.M. (2001) “Microparticles for delivering therapeutic peptides and proteins to the lumen of the small intestine”, Eur. J. Pharm. Biopharm. 52, 39–44.
  • Anderson, K.E., Eliot, L.A., Stevensen, B.R. and Rogers, J.A. (2001a) “Acid-receptor targeted oral vancomycin liposomal dosage form”, Pharm. Res. 18(3),316–322.
  • Anderson, K.E., Elliot, L.A., Stevenson, B.R. and Rogers, J.A. (2001b) “Formulation and evaluation of a folic-acid receptor-targeted oral vancomycin liposomal oral dosage form”., Pharm. Res. 18, 316–322. Artusson P., Palm, K. and Luthman, K. (2001) “Caco-2 monolayers in experimental and theoretical predictions of drug transport”, Adv. Drug Del Rev. 46, 47–63.
  • Bergmann, K.-C., Waldman, R.H., Bicak, M. and Russell-Jones, G.J. (1989) “Adjuvant effect of B-subunit of E. coli heat labile toxin on secretory antibody response to oral influenza virus immunization in mice”, Allergologie 12, 294.
  • Bergman, K.-C., Russell-Jones, G.J. and Waldman, R.H. (1991) “B subunit of E. Coli heat-labile enterotoxin enhances secretory IgA antibody response to oral influenza virus immunization in mice”, Schweiz. Med. Wochenschr. 121(Suppl. 40/II), 28.
  • Bernkop-Schnurch, A., Humenberger, C. and Valenta, C. (1998) “Basic studies on bioadhesive delivery systems for peptide and protein drugs”, Int. J. Pharm. 165, 217–225. Brayden, D.J. (2001) “Oral vaccination in man using antigen in particles: current status”, Eur. J. Pharm. Sci. 14, 183–189.
  • Brayden, D.J. and O’Mahoney, D.J. (1998) “Novel oral delivery gateways for biotechnology products: polypeptides and vaccines”, PSTT 1, 291–299.
  • Chalsani, K.B., Diwan, P.V., Russell-Jones, G.J. and Jain, S.K. (2004) “Novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of peptides/proteins using insulin as a model”, Int. J. Pharm., Manuscript in preparation.
  • Chatterjee, N.S., Kumar, C.K., Oritz, A., Rubin, S.A. and Said, H.M. (1999) “Molecular mechanism of the intestinal biotin transport process”, Am. J. Physiol. 277, C605–C613.
  • Chun, M.-K., Chow, K.S. and Choi, H.-K (2002) “Mucoadhesive drug carrier based on interpolymer complex of poly(vinylpyrrolidone) and poly(acrylicacid) prepared by template polymerization”, J. Control. Release 81, 327–334.
  • Desai, M.P., Labhasetwar, V., Amidon, G.L. and Levy, R.J. (1996) “Gastrointestinal uptake of biodegradable microparticles: effect of particle size”, Pharm. Res. 13, 1838–1845.
  • Easson, J.H., Haltner, E., Lehr, C.M. and Jahn, D. (1999) “Bacterial invasion factors and adhesins as second generation bioadhesives”, In: Mathiowitz, E., Chickering, D.E. and Lehr, C.M., eds, Bioadhesive Drug Delivery Systems (Marcel Dekker, New York), pp 409–432.
  • Fe´ger, J., Gil-Falcon, S. and Lamaze, C. (1994) “Cell receptors: definition, mechanisms and regulation of receptor-mediated endocy- tosis”, Cell. Mol. Biol. 40, 1039–1061.
  • Florence, A.T. and Hussain, N. (2001) “Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas”, Adv. Drug Delivery Rev. 50, S69–S89.
  • Florence, A.T., et al. (1995) “Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate”, J. Control. Release 36, 39–46.
  • Frey, A., Giannasca, K.T., Weltzin, R., Giannasca, P.J., Reggio, H., Lencer, W.I. and Neutra, M.R. (1996) “Role of glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting”, J. Exp. Med. 184, 1045–1059.
  • Gabor, F. and Wirth, M. (1997) “Lectin-mediated bioadhesion: wheat germ agglutinin and Solanum tuberosum lectin as targeting moieties in particulate drug delivery systems”, Eur. J. Cell Biol. 74(Suppl. 46), 12.
  • Gabor, F., Schwarzbauer, A. and Wirth, M. (2002) “Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 cell model”, Int. J. Pharm. 237, 227–239.
  • Geuze, J.J., Slot, J.W., Strou, G.J., Lodish, H.F. and Achwartz, A.L. (1983) “Intracellular site of asialoglycoprotein receptor-ligand uncoupling: double-label immunoelectron microscopy during recep- tor-mediated endocytosis”, Cell 35, 277–287.
  • Habberfield, A., Jensen-Pippo, K., Ralph, L., Westwood, S.W. and Russell-Jones, G.J. (1996) “Vitamin VB12-mediated uptake of recombinant therapeutic proteins from the gut”, Int. J. Pharm. 145, 1–8.
  • Helenius, A., Morein, B., Fries, E., Simons, K., Robinson, P., Schirrmacher, V., Terhorst, C. and Strominger, J.L. (1978) “Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompata- bility antigens are cell surface receptors for Semliki forest virus”, PNAS 75, 3846.
  • Hussain, N., Jani, P.U. and Florence, A.T. (1997) “Enhanced uptake of tomato lectin-conjugated nanoparticles in the rat”, Pharm. Res. 14, 613–618.
  • Hussain, N., Jaitley, V. and Florence, A.T. (2001) “Recent advances in the understanding of uptake of microparticulates across the gastro intestinal lymphatics”, Adv. Drug Delivery Rev. 50, 107–142. Irache, J.M., Durrer, C., Ducheˆne, D. and Ponchel, G. (1996) “Bioadhesion of lectin-latex conjugates to rat intestinal mucosa”, Pharm. Res. 13, 1716–1719.
  • Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J.X. and Kissel, T. (2000) “Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?”, Eur. J. Pharm. Biopharm. 50, 147–160.
  • Kadiyala, I., Roy, K., Rice, J. and Leong, K.W. (2000) “Transport kinetics of DNA nanoparticle in a Caco-2 Peyers’ Patch model of intestinal epithelium”, Proc. Int. Symp. Control. Release Bioact. Mater. 27, #0256.
  • Kamen, B.A. (2002) “Folate receptor a: A review”, In: Rao, M.S., ed., Stem Cells and CNS Development (Humana Press Inc., Totowa NJ).
  • Kumagai, K. (1992) In: Uber den Resorptionvergang der corpuscularen Bestandteile im Darm, Kekkaku-Zassi, Japan.
  • Lazorova´, L., Sjo¨lander, A., Russell-Jones, G.J., Lindner, J. and Artursson, P. (1993) “Intestinal tissue distribution and epithelial transport of the oral immunogen LTB, the B subunit of E. coli heat- labile enterotoxin”, J. Drug Target. 1, 331–340.
  • Lehr, C.M. (2000) “Lectin-mediated drug delivery, the second generation of bioadhesives”, J. Control. Release 65, 19–29.
  • Lehr, C.M., Bouwstra, J.A., Kok, W., Noach, A.B.J., de Boer, A.G. and Junginger, H.E. (1992) “Bioadhesion by means of specific binding of tomato lectin”, Pharm. Res. 9, 547–553.
  • Li, H. and Qian, Z.M. (2002) “Transferrin/transferrin mediated drug delivery”, Med. Res. Rev. 22, 225–250.
  • Lindner, J., Geczy, A.F. and Russell-Jones, G.J. (1994) “Identification of the site of uptake of the E. coli heat-labile enterotoxin, LTB”, Scand. J. Immunol. 40, 564–572.
  • Lomotan, A.E., Brown, K.A., Speaker, T.J. and Offita, P.A. (1997) “Aqueous-based microcapsules are detected primarily in gut- associated dendritic cells after oral inoculation of mice”, Vaccine 15, 1959–1962.
  • Manthey, K.C., Griffin, J.B. and Zempleni, J. (2002) “Biotin supply affects expression of biotin transporters, biotinylation of carboxylases and metabolism of interleukin-2 in Jurkat cells”, J. Nutr. 132, 887–892.
  • Mardach, R., Zempleni, J., Wolf, B., Cannon, M.J., Jennings, M.L., Cress, S., Boylan, J., Roth, S., Cederbaum, S. and Mock, D.M. (2002) “Biotin dependency due to a defect in biotin transport”, J. Clin. Investig. 109, 1617–1623.
  • Maziarz, K.M., Monaco, H.L., Shen, F. and Ratnam, M. (1999) “Complete mapping of amino acids responsible for differential ligand binding of folate receptors a and b”, J. Biol. Chem. 274, 11086–11091. Mostov, K.E. and Simister, N.E. (1985) “Transcytosis”, Cell 43, 389–390.
  • Mostov, K.E., Friedlander, M., and Blobel, G. (1984) “The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains”, Nature (London) 308, 37–43.
  • O’Hagan, D.T. (1990) “Intestinal translocation of particulates— implications for drug and antigen delivery”, Adv. Drug Delivery Rev. 5, 265–285.
  • Page, D.T. and Cudmore, S. (2001) “Innovations in oral gene delivery: challenges and potentials”, DDT 6, 92–101. Pankaj et al. (2002) WO 02/062396.
  • Peppas, N.A., Bures, P., Leobandung, L. and Ichikawa, H. (2000) “Hydrogels in pharmaceutical formulations”, Eur. J. Pharm. Biopharm. 50, 27–46.
  • Pryer, N.K., Wuestehube, L.J. and Schekman, R. (1992) “Vesicle- mediated protein sorting”, Annu. Rev. Biochem. 61, 471–516.
  • Pusztai, A. (1989) “Transport of proteins through the membranes of the adult gastro-intestinal tract—a potential for drug delivery?”, Adv. Drug Delivery Rev. 3, 215–228.
  • Pusztai, A. (1995) “Lectin-targeting of microparticles to different parts of the gastrointestinal tract”, Proc. Int. Symp. Control. Release Bioact. Mater. 22, 161–162.
  • Pusztai, A., Clarke, E.M., Grant, G. and King, T.P. (1981) “The toxicity of Phaseolus vulgaris lectin. Nitrogen balance and immunochemical studies”, J. Sci. Food Agric. 32, 1037–1046.
  • Rodriguez-Boulan, E., Misek, D.E., de Salas, D.V., Salas, P.J.I. and Bard, E. (1985) “Protein sorting in the secretory pathway”, Curr. Top. Membr. Transp. 24, 251–294.
  • Russell-Jones, G.J. (1993a) Oral delivery systems for proteins and peptides: The use of lectins for oral immunization and the use of the VB12-uptake system for the delivery of peptide and protein pharmaceuticals. Proceedings of Business Opportunities in Peptide and Protein Delivery, Leiden, Netherlands.
  • Russell-Jones, G.J. (1993b) “Oral vaccination with lectins and lectin-like molecules”, In: O’Hagan, Derek, ed., Novel Delivery Systems for Oral Vaccine Development (CRC Press, Boca Raton, FL), pp 296–299.
  • Russell-Jones, G.J. (1994) “Oral vaccination with lectins and lectin-like molecules”, In: O’Hagan, D.T., ed., Novel Delivery Systems for Oral Vaccines (CRC Press, Boca Raton, FL), pp 225–240.
  • Russell-Jones, G.J. (1995) “Oral delivery of therapeutic proteins and peptides by the vitamin B12 uptake system”, Peptide-Based Drug Design: Controlling Transport and Metabolism (ACS books, Washington, DC), pp 181–198.
  • Russell-Jones, G.J. (1996a) “The potential use of receptor-mediated endocytosis for oral drug delivery”, Adv. Drug Delivery Rev. 20, 83–97.
  • Russell-Jones, G.J. (1996b) “The potential use of receptor-mediated endocytosis for oral drug delivery”, In: Øie, S., Szoka, F.C. and Swaan, P.W., eds, Carrier Mediated Approaches for Oral Drug Delivery Advanced Drug Delivery Reviews, Vol. 20, pp 83–96.
  • Russell-Jones, G.J. (1998) In: Mathiowitz, Edith, ed., Carrier- Mediated Transport for Oral Drug Delivery. Encyclopedia of Controlled Drug Delivery (To be published by John Wiley & Sons, New York).
  • Russell-Jones, G.J. and Aizpurua, de, H.J. (1987) “Mucosal immunogens”, In: Mestecky, J., McGhee, J.R., Bienenstock, J. and Ogra, P.L., eds, Recent Advances in Mucosal Immunology Adv. Exp. Med. Biol., (Plenum Publishing Co., New York), Vol. 216B, pp 1791–1799.
  • Russell-Jones, G.J. and de Aizpurua, H.J. (1988) “Vitamin B12: a novel carrier for orally presented antigens”, Proc. Int. Symp. Control. Release Bioact. Mater. 15, 142–143.
  • Russell-Jones, G.J. and Westwood, S.W. (1992) Oral delivery systems for microparticles. (USPA 07/956,003; WO 92/17167; PCT/AU92/00141) (Granted).
  • Russell-Jones, G.J., Westwood, S.W. and Habberfield, A. (1996a) The use of the vitamin VB12 transport system as a carrier for the oral delivery of peptides, proteins and nanoparticles. Proceedings of 23rd International Symposium on Controlled Release of Bioactive Materials, pp. 49–50.
  • Russell-Jones, G.J., Westwood, S.W. and Habberfield, A.D. (1996b) “Vitamin VB12-mediated oral delivery systems for granulocyte-colony stimulating factor and erythropoietin”, Bioconjug. Chem. 6, 459–465.
  • Russell-Jones, G.J., Arthur, L., Killinger, S. and Westwood, S.W. (1997) Vitamin B12-mediated transport of nanoparticles. Proceedings of 24th International Symposium on Controlled Release of Bioactive Materials.
  • Russell-Jones, G.J., Arthur, L. and Walker, H. (1998a) “Vitamin B12- mediated transport of nanoparticles across Caco-2 cells”, Int. J. Pharm. 190, 165–174.
  • Russell-Jones, G.J., Walker, H., Killinger, S. and Starling, S. (1998b) Lectin-mediated transport of nanoparticles. Proceedings of 25th International Symposium on Controlled Release of Bioactive Materials.
  • Russell-Jones, G.J., Arthur, L. and Walker, H. (1999a) “Vitamin B12- mediated transport of nanoparticles across Caco-2 cells”, Int. J. Pharm. 179, 247–255.
  • Russell-Jones, G.J., Veitch, H. and Arthur, L. (1999b) “Lectin-mediated transport of nanoparticles across Caco-2 and OK cells”, Int. J. Pharm. 190, 165–174.
  • Schatzlein, A.G., Rutherford, C., Tufail, U. and Moore, B.D. (2000) “Peptides as ligands for drug targeting”, Proc. Int. Symp. Control. Release Bioact. Mater. 27, #0256.
  • Shar, D. and Shen, W.C. (1996) “Transcellular delivery of an insulin- tranferrin conjugate in enterocyte-like Caco-2 cells”, J. Pharm. Sci. 85, 1306–1311.
  • Simons, K. and Fuller, S.D. (1985) “Cell surface polarity in epithelia”, Annu. Rev. Cell Biol. 1, 243–288.
  • Singla, A.K., Chawla, M. and Singh, A. (2000) “Potential applications of carbomer in oral mucoadhesion drug delivery system: a review”, Drug Dev. Ind. Pharm. 26(9),913–924.
  • Smith, M.W., Thomas, N.W., Jenkins, P.G., Miller, N.G.A., Cremaschi, D. and Porta, C. (1995) “Selective transport of microparticles across Peyer’s patch follicle-associated M cells from mice and rats”, Exp. Physiol. 80, 735–743.
  • Stanley, J.S., Mock, D.M., Griffin, J.B. and Zempleni, J. (2002) “Biotin uptake into human peripheral blood mononuclear cells increases early in the cell cycle, increasing carboxylase activities”, J. Nutr. 132, 1854–1859.
  • Tavelin, S., Taipalensuu, J., Soderberg, L., Morrison, R., Chong, S. and Artusson, P. (2003) “Prediction of the oral absorption of low- permeability drugs using small intestine-like 2/4/A1 cell mono- layers”, Pharm. Res. 20, 397–405.
  • Wang, J., Shen, D. and Shen, W.C. (1997) “Oral delivery of insulin-transferrin conjugate in streptozotocin-treated CF/1 mice”, Pharm. Res. Suppl. 14, 469.
  • Xia, C.G., Wang, J. and Shen, W.C. (2000) “Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats”, J. Pharmacol. Exp. Ther. 295, 574–600.
  • Zemplini, J. and Mock, D.M. (1999) “Human peripheral blood mononuclear cells: inhibition of biotin transport by reversible competition with pantothenic acid is relatively minor”, J. Nutr. Biochem. 10, 427–432.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.